OpenFilings

NRX Pharmaceuticals, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-03-29

Time Filed17:18:08

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.8
EX-4.9
EX-10.55
EX-10.60
EX-10.64
EX-10.66
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-97.1
Filing on SEC Edgar